How lung cancer triggers pulmonary hypertension
Nearly half of all advanced-stage lung cancer patients develop arterial pulmonary hypertension – DZL scientists of…
- DZL
- Research
- Clinical Impact
- DZL Academy
- News
- Service
Nearly half of all advanced-stage lung cancer patients develop arterial pulmonary hypertension – DZL scientists of…
Chronic infections with the pathogen Pseudomonas aeruginosa change the lung microbiome in CF-patients.
Theis and colleagues have shown how data from individual blood stem cells can be used to determine their fate...
Premature babies that need ventilation to support their breathing often suffer from a condition known as bronchopulmonary dysplasia. Researchers of the DZL Sites Munich and Giessen and further institutions have now discovered a molecular mechanism...
Pulmonary fibrosis can possibly be attributed to a kind of cellular aging process, which is called senescence. This has been shown by researchers from the DZL sites Munich and Giessen. As they report in the...
Promising Model for Medical Research...
A new study under the lead of DZL scientists has shown, autoimmune reactions may be a causal factor in more patients as currently expected. The results have been published in the ‘American Journal of Respiratory...
Scientists from the German Center for Lung Research (DZL) developed an animal model of severe iron overload to investigate the mechanisms of pulmonary iron deposition and their effects on lung function.
Cystic Fibrosis: Junior Scientist Dr. Patricia Morán Losada...
DZL Scientist Dr. Darcy E. Wagner, member of the Research Unit „Lung Repair and Regeneration“ at the DZL Site CPC-Munich and member of the Helmholtz Munich Postdoctoral Fellowship Program has been selected as a Science...
Dr. Rajkumar Savai from the Max Planck Institute for Heart and Lung Reseach (MPI) in Bad Nauheim (DZL site UGMLC) has recently received the Early Career Achievement Award from the American Thoracic Society (ATS) International...
